Skip to main content

Fat Tissue Analysis in the Management of Patients with Systemic Amyloidosis

  • Chapter

Part of the book series: Current Clinical Pathology ((CCPATH))

Abstract

Aspiration of abdominal subcutaneous fat tissue is a safe, inexpensive, reliable, minimally invasive, and easy procedure with high diagnostic yield that can be done early after clinical suspicion of amyloidosis and can be repeated if required anytime during the course of the disease. Material obtained in this way is highly suitable for detection, typing, and quantification of amyloid and can also be used for chemical tissue analysis using proteomic techniques. The procedure has great potential to enable dynamic research of local tissue factors involved both in deposition and removal of amyloid in vivo. In the Appendix of this chapter, we describe the current practice of this procedure in our center.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Schilder P. Über die amyloide Entartung der Haut. Frankfurt Z Pathol. 1909;3:782–94.

    Google Scholar 

  2. Westermark P, Stenkvist B. Diagnosis of secondary generalized amyloidosis by fine needle biopsy of the skin. Acta Med Scand. 1971;190:453–4.

    CAS  PubMed  Google Scholar 

  3. Westermark P, Stenkvist B. A new method for the diagnosis of systemic amyloidosis. Arch Intern Med. 1973;132:522–3.

    CAS  PubMed  Google Scholar 

  4. Westermark P, Stenkvist B, Natvig JB, et al. Demonstration of protein AA in subcutaneous fat tissue obtained by fine needle biopsy. Ann Rheum Dis. 1979;38:68–71.

    PubMed Central  CAS  PubMed  Google Scholar 

  5. Libbey CA, Skinner M, Cohen AS. Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis. Arch Intern Med. 1983;143:1549–52.

    CAS  PubMed  Google Scholar 

  6. Breedveld FC, Markusse HM, MacFarlane JD. Subcutaneous fat biopsy in the diagnosis of amyloidosis secondary to chronic arthritis. Clin Exp Rheumatol. 1989;7:407–10.

    CAS  PubMed  Google Scholar 

  7. Westermark P. Diagnosis and characterization of systemic amyloidosis by biopsy of subcutaneous abdominal fat tissue. Intern Med Specialist. 1984;5:154–60.

    Google Scholar 

  8. Olsen KE, Sletten K, Westermark P. The use of subcutaneous fat tissue for amyloid typing by enzyme-linked immunosorbent assay. Am J Clin Pathol. 1999;111:355–62.

    CAS  PubMed  Google Scholar 

  9. Westermark P. Subcutaneous adipose tissue biopsy for amyloid protein studies. Methods Mol Biol. 2012;849:363–71.

    CAS  PubMed  Google Scholar 

  10. Hazenberg BP, Limburg PC, Bijzet J, van Rijswijk MH. A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis. Ann Rheum Dis. 1999;58:96–102.

    PubMed Central  CAS  PubMed  Google Scholar 

  11. Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem. 1962;10:355–63.

    CAS  Google Scholar 

  12. Picken MM. Amyloidosis-where are we now and where are we heading? Arch Pathol Lab Med. 2010;134:545–51.

    PubMed  Google Scholar 

  13. Giorgadze TA, Shiina N, Baloch ZW, Tomaszewski JE, Gupta PK. Improved detection of amyloid in fat pad aspiration: an evaluation of Congo red stain by fluorescent microscopy. Diagn Cytopathol. 2004;31:300–6.

    PubMed  Google Scholar 

  14. Ishii W, Matsuda M, Nakamura N, et al. Phenol Congo red staining enhances the diagnostic value of abdominal fat aspiration biopsy in reactive AA amyloidosis secondary to rheumatoid arthritis. Intern Med. 2003;42:400–5.

    PubMed  Google Scholar 

  15. Ponce P, Carvalho F, Coelho A. Valeur de la ponction-aspiration de la graisse sous-cutanée dans le diagnostic de l’amylose. Nephrologie. 1986;7:25–7.

    CAS  PubMed  Google Scholar 

  16. Klemi PJ, Sorsa S, Happonen RP. Fine-needle aspiration biopsy from subcutaneous fat. An easy way to diagnose secondary amyloidosis. Scand J Rheumatol. 1987;16:429–31.

    CAS  PubMed  Google Scholar 

  17. Gertz MA, Li CY, Shirahama T, Kyle RA. Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain). Arch Intern Med. 1988;148:929–33.

    CAS  PubMed  Google Scholar 

  18. Sorsa S, Happonen RP, Klemi P. Oral biopsy and fine needle aspiration biopsy from subcutaneous fat in diagnosis of secondary amyloidosis. Int J Oral Maxillofac Surg. 1988;17:14–6.

    CAS  PubMed  Google Scholar 

  19. Duston MA, Skinner M, Meenan RF, Cohen AS. Sensitivity, specificity, and predictive value of abdominal fat aspiration for the diagnosis of amyloidosis. Arthritis Rheum. 1989;32:82–5.

    CAS  PubMed  Google Scholar 

  20. Dupond JL, de Wazières B, Saile R, et al. L’amylose systémique du sujet âgé: valeur diagnostique de l’examen de la graisse sous-cutanée abdominale et des glandes salivaires accessoires. Étude prospective chez 100 patients âgés. Rev Med Interne. 1995;16:314–7.

    CAS  PubMed  Google Scholar 

  21. Masouye I. Diagnostic screening of systemic amyloidosis by abdominal fat aspiration: an analysis of 100 cases. Am J Dermatopathol. 1997;19:41–5.

    CAS  PubMed  Google Scholar 

  22. Guy CD, Jones CK. Abdominal fat pad aspiration biopsy for tissue confirmation of systemic amyloidosis: specificity, positive predictive value, and diagnostic pitfalls. Diagn Cytopathol. 2001;24:181–5.

    CAS  PubMed  Google Scholar 

  23. Ansari-Lari MA, Ali SZ. Fine-needle aspiration of abdominal fat pad for amyloid detection: a clinically useful test? Diagn Cytopathol. 2004;30:178–81.

    PubMed  Google Scholar 

  24. van Gameren II, Hazenberg BP, Bijzet J, van Rijswijk MH. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum. 2006;54:2015–21.

    PubMed  Google Scholar 

  25. Dhingra S, Krishnani N, Kumari N, Pandey R. Evaluation of abdominal fat pad aspiration cytology and grading for detection in systemic amyloidosis. Acta Cytol. 2007;51:860–4.

    PubMed  Google Scholar 

  26. Blumenfeld W, Hildebrandt RH. Fine needle aspiration of abdominal fat for the diagnosis of amyloidosis. Acta Cytol. 1993;37:170–4.

    CAS  PubMed  Google Scholar 

  27. Lipschutz JH, Miller T, Yen TS, Vartanian RK, Graber ML, Damon L. Unreliability of the abdominal fat pad biopsy in the evaluation of nephrosis: report of 3 consecutive cases. Am J Nephrol. 1995;15:431–5.

    CAS  PubMed  Google Scholar 

  28. Andrews TR, Colon-Otero G, Calamia KT, Menke DM, Boylan KB, Kyle RA. Utility of subcutaneous fat aspiration for diagnosing amyloidosis in patients with isolated peripheral neuropathy. Mayo Clin Proc. 2002;77:1287–90.

    PubMed  Google Scholar 

  29. Päi S, Helin H, Isomäki H. Frequency of amyloidosis in Estonian patients with rheumatoid arthritis. Scand J Rheumatol. 1993;22:248–9.

    PubMed  Google Scholar 

  30. Tiitinen S, Kaarela K, Helin H, Kautiainen H, Isomäki H. Amyloidosis–incidence and early risk factors in patients with rheumatoid arthritis. Scand J Rheumatol. 1993;22:158–61.

    CAS  PubMed  Google Scholar 

  31. Gratacos J, Orellana C, Sanmarti R, et al. Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration. J Rheumatol. 1997;24:912–5.

    CAS  PubMed  Google Scholar 

  32. El Mansoury TM, Hazenberg BP, El Badawy SA, et al. Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics. Ann Rheum Dis. 2002;61:42–7.

    PubMed Central  PubMed  Google Scholar 

  33. Ishii W, Matsuda M, Nakamura A, Nakamura N, Suzuki A, Ikeda S. Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis. Intern Med. 2003;42:800–5.

    CAS  PubMed  Google Scholar 

  34. Alishiri GH, Salimzadeh A, Owlia MB, Forghanizadeh J, Setarehshenas R, Shayanfar N. Prevalence of amyloid deposition in long standing rheumatoid arthritis in Iranian patients by abdominal subcutaneous fat biopsy and assessment of clinical and laboratory characteristics. BMC Musculoskelet Disord. 2006;7:43.

    PubMed Central  PubMed  Google Scholar 

  35. Singh G, Kumari N, Aggarwal A, Krishnani N, Misra R. Prevalence of subclinical amyloidosis in ankylosing spondylitis. J Rheumatol. 2007;34:371–3.

    PubMed  Google Scholar 

  36. Wakhlu A, Krisnani N, Hissaria P, Aggarwal A, Misra R. Prevalence of secondary amyloidosis in Asian North Indian patients with rheumatoid arthritis. J Rheumatol. 2003;30:948–51.

    PubMed  Google Scholar 

  37. Wiland P, Wojtala R, Goodacre J, Szechinski J. The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis. Clin Rheumatol. 2004;23:193–8.

    PubMed  Google Scholar 

  38. Fine NM, Arruda-Olson AM, Dispenzieri A, et al. Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis. Am J Cardiol. 2014;113:1723–7.

    CAS  PubMed  Google Scholar 

  39. Ikeda S, Sekijima Y, Tojo K, Koyama J. Diagnostic value of abdominal wall fat pad biopsy in senile systemic amyloidosis. Amyloid. 2011;18:211–5.

    PubMed  Google Scholar 

  40. Takashio S, Izumiya Y, Jinnin M, et al. Diagnostic and prognostic value of subcutaneous tissue biopsy in patients with cardiac amyloidosis. Am J Cardiol. 2012;110:1507–11.

    PubMed  Google Scholar 

  41. Sipe JD, Benson MD, Buxbaum JN, et al. Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid. 2012;19:167–70.

    CAS  PubMed  Google Scholar 

  42. Arbustini E, Verga L, Concardi M, Palladini G, Obici L, Merlini G. Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis. Amyloid. 2002;9:108–14.

    CAS  PubMed  Google Scholar 

  43. Hazenberg AJ, Dikkers FG, Hawkins PN, et al. Laryngeal presentation of systemic AApoAI amyloidosis in patients with apolipoprotein AI variants Leu174Ser and Leu178Pro. Laryngoscope. 2009;119:608–15.

    CAS  PubMed  Google Scholar 

  44. Varga J, Idelson BA, Felson D, Skinner M, Cohen AS. Lack of amyloid in abdominal fat aspirates from patients undergoing long-term hemodialysis. Arch Intern Med. 1987;147:1455–7.

    CAS  PubMed  Google Scholar 

  45. Orfila C, Goffinet F, Goudable C, et al. Unsuitable value of abdominal fat tissue aspirate examination for the diagnosis of amyloidosis in long-term hemodialysis patients. Am J Nephrol. 1988;8:454–6.

    CAS  PubMed  Google Scholar 

  46. Solé Arqués M, Campistol JM, Muñoz-Gómez J. Abdominal fat aspiration biopsy in dialysis-related amyloidosis. Arch Intern Med. 1988;148:988.

    PubMed  Google Scholar 

  47. Sethi D, Cary NR, Brown EA, Woodrow DF, Gower PE. Dialysis-associated amyloid: systemic or local? Nephrol Dial Transplant. 1989;4:1054–9.

    CAS  PubMed  Google Scholar 

  48. Uemichi T, Liepnieks JJ, Gertz MA, Benson MD. Fibrinogen A alpha chain Leu 554: an African-American kindred with late onset renal amyloidosis. Amyloid. 1998;5:188–92.

    CAS  PubMed  Google Scholar 

  49. Westermark P, Davey E, Lindbom K, Enqvist S. Subcutaneous fat tissue for diagnosis and studies of systemic amyloidosis. Acta Histochem. 2006;108:209–13.

    PubMed  Google Scholar 

  50. Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid. 1998;5:55–66.

    CAS  PubMed  Google Scholar 

  51. Vrana JA, Theis JD, Dasari S, Mereuta OM, Dispenzieri A, Zeldenrust SR, Gertz MA, Kurtin PJ, Grogg KL, Dogan A. Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based. Haematologica. 2014;99:1239–47.

    PubMed Central  CAS  PubMed  Google Scholar 

  52. Sie MP, van der Wiel HE, Smedts FM, de Boer AC. Human recombinant insulin and amyloidosis: an unexpected association. Neth J Med. 2010;68:138–40.

    CAS  PubMed  Google Scholar 

  53. Shikama Y, Kitazawa J, Yagihashi N, et al. Localized amyloidosis at the site of repeated insulin injection in a diabetic patient. Intern Med. 2010;49:397–401.

    PubMed  Google Scholar 

  54. D’Souza A, Theis JD, Vrana JA, Buadi F, Dispenzieri A, Dogan A. Localized insulin-derived amyloidosis: a potential pitfall in the diagnosis of systemic amyloidosis by fat aspirate. Am J Hematol. 2012;87:E131–2.

    PubMed  Google Scholar 

  55. Orfila C, Giraud P, Modesto A, Suc JM. Abdominal fat tissue aspirate in human amyloidosis: light, electron, and immunofluorescence microscopic studies. Hum Pathol. 1986;17:366–9.

    CAS  PubMed  Google Scholar 

  56. Halloush RA, Lavrovskaya E, Mody DR, Lager D, Truong L. Diagnosis and typing of systemic amyloidosis: the role of abdominal fat pad fine needle aspiration biopsy. Cytojournal. 2010;6:24.

    PubMed Central  PubMed  Google Scholar 

  57. Ihse E, Ybo A, Suhr O, Lindqvist P, Backman C, Westermark P. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol. 2008;216:253–61.

    CAS  PubMed  Google Scholar 

  58. Kaplan B, Vidal R, Kumar A, Ghiso J, Gallo G. Immunochemical microanalysis of amyloid proteins in fine-needle aspirates of abdominal fat. Am J Clin Pathol. 1999;112:403–7.

    CAS  PubMed  Google Scholar 

  59. De Larrea CF, Verga L, Morbini P, et al. Immuno-electron microscopy in the classification of systemic amyloidosis: experience in 423 patients from a single institution. XIVth International symposium on amyloidosis 2014 “Amyloid: Insoluble, but solvable”. Indianapolis, 2014; Abstract OP-15, p. 32–3.

    Google Scholar 

  60. Fernández de Larrea C, Verga L, Morbini P, et al. A practical approach to the diagnosis of systemic amyloidoses. Blood. 2015;125:2239–44.

    Google Scholar 

  61. Hazenberg BP, Bijzet J, Limburg PC, et al. Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis. Amyloid. 2007;14:133–40.

    CAS  PubMed  Google Scholar 

  62. Tishler M, Pras M, Yaron M. Abdominal fat tissue aspirate in amyloidosis of familial Mediterranean fever. Clin Exp Rheumatol. 1988;6:395–7.

    CAS  PubMed  Google Scholar 

  63. Sjöholm K, Palming J, Olofsson LE, et al. A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J Clin Endocrinol Metab. 2005;90:2233–9.

    PubMed  Google Scholar 

  64. Bijzet J, de Boer L, Haagsma EB, Hazenberg BP. An indirect ELISA for transthyretin quantification in fat tissue of patients with ATTR amyloidosis. In: Hazenberg BP, Bijzet J, editors. XIIIth International symposium on amyloidosis 2012 “From misfolded proteins to well-designed treatment”. Groningen: GUARD; 2013. p. 168–70.

    Google Scholar 

  65. Bijzet J, van Gameren II, Limburg PC, Bos R, Vellenga E, Hazenberg BP. Diagnostic performance of measuring free light chains in fat tissue of patients with AL amyloidosis. Amyloid. 2011;18 Suppl 1:71–2.

    PubMed  Google Scholar 

  66. Picken MM, Herrera GA. The burden of “sticky” amyloid: typing challenges. Arch Pathol Lab Med. 2007;131:850–1.

    PubMed  Google Scholar 

  67. Picken MM. New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens. 2007;16:196–203.

    PubMed  Google Scholar 

  68. Pras M, Schubert M, Zucker-Franklin D, et al. The characterization of soluble amyloid prepared in water. J Clin Invest. 1968;47:924–33.

    CAS  PubMed  Google Scholar 

  69. Glenner GG, Wong CW. Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984;120:885–90.

    CAS  PubMed  Google Scholar 

  70. Westermark P, Benson L, Juul J, Sletten K. Use of subcutaneous abdominal fat biopsy specimen for detailed typing of amyloid fibril protein-AL by amino acid sequence analysis. J Clin Pathol. 1989;42:817–9.

    PubMed Central  CAS  PubMed  Google Scholar 

  71. Forsberg AH, Sletten K, Benson L, et al. Abdominal fat biopsy for characterization of the major amyloid fibril proteins by amino acid sequence. In: Natvig JB, Forre O, Husby G, editors. Amyloid and amyloidosis 1990. Norwell, MA: Kluver Academic; 1990. p. 797–800.

    Google Scholar 

  72. Olsen KE, Sletten K, Westermark P. Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain. Biochem Biophys Res Commun. 1998;245:713–6.

    CAS  PubMed  Google Scholar 

  73. Kaplan B, Hrncic R, Murphy CL, Gallo G, Weiss DT, Solomon A. Microextraction and purification techniques applicable to chemical characterization of amyloid proteins in minute amounts of tissue. Methods Enzymol. 1999;309:67–81.

    CAS  PubMed  Google Scholar 

  74. Kaplan B, Murphy CL, Ratner V, Pras M, Weiss DT, Solomon A. Micro-method to isolate and purify amyloid proteins for chemical characterization. Amyloid. 2001;8:22–9.

    CAS  PubMed  Google Scholar 

  75. Kaplan B, Shtrasburg S, Pras M. Micropurification techniques in the analysis of amyloid proteins. J Clin Pathol. 2003;56:86–90.

    PubMed Central  CAS  PubMed  Google Scholar 

  76. Murphy CL, Eulitz M, Hrncic R, et al. Chemical typing of amyloid protein contained in formalin-fixed paraffin-embedded biopsy specimens. Am J Clin Pathol. 2001;116:135–42.

    CAS  PubMed  Google Scholar 

  77. Kaplan B, Martin BM, Livneh A, Pras M, Gallo GR. Biochemical subtyping of amyloid in formalin-fixed tissue samples confirms and supplements immunohistologic data. Am J Clin Pathol. 2004;121:794–800.

    CAS  PubMed  Google Scholar 

  78. Murphy CL, Wang S, Williams T, Weiss DT, Solomon A. Characterization of systemic amyloid deposits by mass spectrometry. Methods Enzymol. 2006;412:48–62.

    CAS  PubMed  Google Scholar 

  79. Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen 3rd HR, Dogan A. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 2009;114:4957–9.

    CAS  PubMed  Google Scholar 

  80. Lavatelli F, Perlman DH, Spencer B, et al. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol Cell Proteomics. 2008;7:1570–83.

    PubMed Central  CAS  PubMed  Google Scholar 

  81. Brambilla F, Lavatelli F, Di Silvestre D, et al. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue. Blood. 2012;119:1844–7.

    CAS  PubMed  Google Scholar 

  82. Brambilla F, Lavatelli F, Di Silvestre D, et al. Shotgun protein profile of human adipose tissue and its changes in relation to systemic amyloidoses. J Proteome Res. 2013;12:5642–55.

    CAS  PubMed  Google Scholar 

  83. Lavatelli F, Vrana JA. Proteomic typing of amyloid deposits in systemic amyloidoses. Amyloid. 2011;18:177–82.

    CAS  PubMed  Google Scholar 

  84. Westermark P. Amyloid diagnosis, subcutaneous adipose tissue, immunohistochemistry and mass spectrometry. Amyloid. 2011;18:175–6.

    PubMed  Google Scholar 

  85. Kimmich C, Hegenbart U, Schönland SO, Bijzet J, Hazenberg BP. Introduction of fat aspiration at a tertiary institution to diagnose systemic amyloidosis. In: Benson MD, Kluve-Beckerman B, Liepnieks JJ, editors. XIVth International symposium on amyloidosis 2014 “Amyloid: Insoluble, but solvable”. Indianapolis; 2014.

    Google Scholar 

  86. Gómez-Casanovas E, Sanmartí R, Solé M, Cañete JD, Muñoz-Gómez J. The clinical significance of amyloid fat deposits in rheumatoid arthritis: a systematic long-term followup study using abdominal fat aspiration. Arthritis Rheum. 2001;44:66–72.

    PubMed  Google Scholar 

  87. Bardarov S, Michael CW, Pu RT, Pang Y. Computer-assisted image analysis of amyloid deposits in abdominal fat pad aspiration biopsies. Diagn Cytopathol. 2009;37:30–5.

    PubMed  Google Scholar 

  88. van Gameren II, Hazenberg BP, Bijzet J, et al. Amyloid load in fat tissue in patients with amyloidosis reflects disease severity and predicts survival. Arthritis Care Res (Hoboken). 2010;62:296–301.

    Google Scholar 

  89. Haagsma EB, van Gameren II, Bijzet J, Posthumus MD, Hazenberg BP. Familial amyloidotic polyneuropathy: long-term follow-up of abdominal fat tissue aspirate in patients with and without liver transplantation. Amyloid. 2007;14:221–6.

    CAS  PubMed  Google Scholar 

  90. Tsuchiya A, Yazaki M, Kametani F, Takei Y, Ikeda S. Marked regression of abdominal fat amyloid in patients with familial amyloid polyneuropathy during long-term follow-up after liver transplantation. Liver Transpl. 2008;14:563–70.

    PubMed  Google Scholar 

  91. Tsuchiya-Suzuki A, Yazaki M, Kametani F, Sekijima Y, Ikeda S. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met. Hum Pathol. 2011;42:236–43.

    CAS  PubMed  Google Scholar 

  92. Ihse E, Suhr OB, Hellman U, Westermark P. Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis. J Mol Med. 2011;89:171–80.

    PubMed Central  CAS  PubMed  Google Scholar 

  93. Ihse E, Rapezzi C, Merlini G, et al. Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis. Amyloid. 2013;20:142–50.

    CAS  PubMed  Google Scholar 

  94. van Gameren II, van Rijswijk MH, Bijzet J, Vellenga E, Hazenberg BP. Histological regression of amyloid in AL amyloidosis is exclusively seen after normalization of serum free light chain. Haematologica. 2009;94:1094–100.

    PubMed Central  PubMed  Google Scholar 

  95. Nilsson KP, Ikenberg K, Åslund A, et al. Structural typing of systemic amyloidosis by luminescent-conjugated polymer spectroscopy. Am J Pathol. 2010;176:563–74.

    PubMed Central  CAS  PubMed  Google Scholar 

  96. Sjölander D, Bijzet J, Hazenberg BP, Nilsson KP, Hammarström P. Sensitive and rapid assessment of amyloid by oligothiophene fluorescence in subcutaneous fat tissue. Amyloid. 2015;22(1):19–25.

    PubMed  Google Scholar 

  97. Poitou C, Viguerie N, Cancello R, et al. Serum amyloid A: production by human white adipocyten and regulation by obesity and nutrition. Diabetologia. 2005;48:519–28.

    CAS  PubMed  Google Scholar 

  98. Upragarin N, Landman WJ, Gaastra W, Gruys E. Extrahepatic production of acute phase serum amyloid A. Histol Histopathol. 2005;20:1295–307.

    CAS  PubMed  Google Scholar 

  99. Kluve-Beckerman B, Liepnieks JJ, Wang L, Benson MD. A cell culture system for the study of amyloid pathogenesis. Amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A. Am J Pathol. 1999;155:123–33.

    PubMed Central  CAS  PubMed  Google Scholar 

  100. Elimova E, Kisilevsky R, Szarek WA, Ancsin JB. Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy. FASEB J. 2004;18:1749–51.

    CAS  PubMed  Google Scholar 

  101. Magy N, Benson MD, Liepnieks JJ, Kluve-Beckerman B. Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model. Amyloid. 2007;14:51–63.

    CAS  PubMed  Google Scholar 

  102. Ishii W, Liepnieks JJ, Yamada T, Benson MD, Kluve-Beckerman B. Human SAA1-derived amyloid deposition in cell culture: a consistent model utilizing human peripheral blood mononuclear cells and serum-free medium. Amyloid. 2013;20:61–71.

    CAS  PubMed  Google Scholar 

  103. Fat aspiration procedure for the detection of amyloid—instruction video. http://www.amyloid.nl/investigations.htm. Accessed 14 July 2014.

  104. Kettwich LG, Sibbitt Jr WL, Emil NS, et al. New device technologies for subcutaneous fat biopsy. Amyloid. 2012;19:66–73.

    PubMed Central  PubMed  Google Scholar 

  105. Devata S, Hari P, Markelova N, Li R, Komorowski R, Shidham VB. Detection of amyloid in abdominal fat pad aspirates in early amyloidosis: role of electron microscopy and Congo red stained cell block sections. Cytojournal. 2011;8:11.

    PubMed Central  PubMed  Google Scholar 

  106. Shidham VB, Hunt B, Jardeh SS, Barboi AC, Devata S, Hari P. Performing and processing FNA of anterior fat pad for amyloid. J Vis Exp. 2010;30(44). pii: 1747.

    Google Scholar 

  107. Jager PL, Hazenberg BP, Franssen EJ, Limburg PC, van Rijswijk MH, Piers DA. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value. J Nucl Med. 1998;39:699–706.

    CAS  PubMed  Google Scholar 

  108. Commercial kit for SAA ELISA. http://www.hycultbiotech.com/products/innate-immunity/acute-phase-proteins/acute-phase-proteins-saa-human-elisa-kit-p11209-html. Accessed 14 July 2014.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bouke P. C. Hazenberg .

Editor information

Editors and Affiliations

Appendices

Appendix: Fat Aspiration Technique and Tissue Analysis Currently Practiced in Groningen

Fat Aspiration Technique

Stepwise Description of the Procedure

Aspiration of abdominal subcutaneous fat tissue is a simple outpatient procedure and a modification of the procedure was described by Gertz [17]. It should be noted that it takes at least 10–15 min to avoid unnecessary pain and bruising and to get adequate material. The patient should be told that bruising might occur. For a description and instruction video of the fat aspiration procedure one can visit our website www.amyloid.nl [103]. Alternative procedures have been described, such as by Kettwich et al. [104] and also for preparing and performing electron microscopy on fat tissue [105, 106].

See Table 16.3 for the equipment we use. A syringe of 10 ml is connected by a valve system to a 16-gauge needle (Fig. 16.5a). After closing the valve, the plunger is pulled out, fixed transiently between squeezed thumb and finger, the cap of the lidocaine needle is reused elegantly by positioning it upside-down inside the plunger (Tarek’s trick) to fix firmly and definitely the position of the plunger, and thus maintaining negative pressure in the syringe during aspiration (Fig. 16.5b). The skin of the patient is marked and cleansed (e.g., with chloorhexidine) at both sides of the umbilicus at about 7–10 cm distance. Check first that the patient is not allergic to lidocaine. Skin and subcutaneous tissue (three directions, see below) are then anesthetized with lidocaine (each side 2 ml = 20 mg).

Table 16.3 Equipment for the fat aspiration
Fig. 16.5
figure 5

(a) The closed valve; reusing the needle cap. (b) Pull and fix the plunger and position the needle cap

After inserting the needle beneath the skin, the valve is opened to start aspiration of fat tissue (Fig. 16.6a). The needle can be moved into three directions (Northeast, East, and Southeast) at the left side of the abdomen and mirror-wise at the right side. The aspiration procedure should be performed slowly and gently into each of the three directions, going to and fro with some axial rotation, and one should realize that it will take some time before the needle will be filled with fat tissue and the first fat can be seen passing the valve and entering the top of the syringe. This should be continued at both sides of the umbilicus until at least 60 mg of fat tissue has been collected (Fig. 16.6b). After the procedure has been finished, the puncture site should be covered with a band aid and pressed for a while to prevent substantial bruising.

Fig. 16.6
figure 6

(a) Insert the needle beneath the skin and open the valve. (b) Yield: about 60 mg of fat tissue

The next step may be as simple as this: Seal the syringe, keep it cool (4 °C) until shipment, and send it at room temperature to a diagnostic center (e.g., UMC Groningen) for analysis as soon as possible, but at the latest arriving there within 1 week after the procedure.

Frequently Encountered Problems During the Procedure

Two technical problems can be encountered during aspiration: no tissue at all or too much blood entering the syringe.

If no fat appears in the syringe or the aspiration has stopped completely for some time, the needle may have become obstructed. The simplest way to check this is to pull the needle out of the patient. Normally, fat tissue present in the needle is then directly and audibly forced into the syringe because of negative pressure. If this is not the case and fat tissue obstructs the needle completely, tissue in the needle can be removed by using positive pressure in the syringe. This may result in a rather explosive evacuation (firing fat tissue) and should therefore be carried out carefully. The needle is introduced into a clean container (e.g., sputum or urine) or empty syringe: tissue is then evacuated into this container or syringe, while fixing the needle firmly to the syringe to prevent the needle leaving the syringe (firing needles).

If much arterial or venous blood enters the syringe by accident, the needle should be removed out of the body. The puncture site should be pressed for at least 1 min, and the procedure can be repeated into a different direction or at a different site. Pain is infrequent, localized, and seldom a real problem necessitating the use of more lidocaine. If bruising is suspected to be present at the end of the procedure, the patient him/herself may press the puncture site for a couple of minutes before rising from the supine position. At the end of the procedure, after sealing the two syringes, both puncture sites should be inspected for the development of significant bruising. If these safety precautions are taken routinely, the chance of severe bleeding or infections is very small. In about 2,000 procedures in our hospital, we observed twice a bleeding complication necessitating surgical assistance to find and stop the bleeding locus and once a local infection of the abdominal wall necessitating surgical drainage after incision combined with antibiotic treatment.

Congo Red Stain and Grading of Amyloid in Fat Tissue

Preparing Slides for Microscopy

After extracting the plunger, fat tissue can be collected from the syringe on an empty glass slide to separate fat tissue from accidentally obtained blood. At least four visible fragments of fat tissue (not fat droplets!) should be put on each of three glass slides (preferably with a frosted edge, which can be used to write on it with a pencil). These fragments are crushed into a single layer by squeezing a second slide placed perpendicularly to the first ones (Fig. 16.7a, b). It is important to press in the middle of the glass slides to prevent breaking of glass. The resulting six smears are marked for identification, dried in the air at room temperature for 1 h, and subsequently fixed with acetone for 10 min. After drying and fixation, all slides can be stored at room temperature until shipped to a reference laboratory for staining with Congo red and further study if positive for amyloid. Fat tissue should not be frozen before slides have been made: freezing of fresh and unfixed tissue may affect the quality of the tissue.

Fig. 16.7
figure 7

(a) Perpendicularly positioned glass slides. (b) Squeezing in the middle of the glass slides

Congo Red Stain, Microscopy, and Amyloid Grading

Staining with alkaline Congo red should be performed according to the classic method described by Puchtler [11]. See Table 16.4 for a short summary. Commercial kits for Congo red stain are also available and have been used successfully, in particular in the US (MM Picken, personal communication).

Table 16.4 Alkaline Congo red stain according to Puchtler [11]

The affinity of tissue for Congo red can be analyzed by the apple-green birefringence in polarized light using a good microscope. In our institution, we use the Olympus BX 50 microscope and a strong (100 W) light source. Two investigators score the slides blinded to the clinical data and in a semiquantitative grading system (Fig. 16.2): 0 (negative, no apple-green birefringence detectable), 1+ (minute, <1 % of surface area), 2+ (little, between 1 % and 10 %), 3+ (moderate, between 10 % and 60 %), 4+ (abundant, >60 %). Because some deposits may be tiny and hardly visible in daylight conditions, the slides, ideally, should be read in the dark. Kimmich et al. show nicely how this technique reliably can be introduced and successfully implemented in another center [85].

Immunochemical Quantification of Amyloid Proteins in Fat Tissue Extracts

Aim of the fat aspiration procedure is to obtain first an adequate quantity for microscopic analysis (3 × 4 lumps with total weight about 30 mg) and further at least 30 mg of fat tissue for immunochemical quantification of the amyloid proteins. After extracting the plunger, fat tissue is collected from the syringe on an empty glass slide to separate fat tissue from accidentally obtained blood and the 12 lumps of fat are used for the smears (vide supra). Before quantification, the amount of fat is weighed to get the “wet weight.” The material is then first washed 3× in a Tris buffer supplemented with calcium to remove possible remnants of blood still present. Subsequently SAP is extracted from this solution by incubation for 24 h with a Tris buffer supplemented with EDTA and the SAP concentration can be measured in this extract by ELISA [107].

The washed fat tissue is then extracted in a solution of 6 M guanidine hydrochloride and 0.1 M Tris–HCl, pH 8.0, mixed thoroughly, and shaken overnight. The suspension is centrifuged at 10,000×g for 10 min and the supernatant fat tissue extract collected. Microtiter plates are coated with the IgG fraction of the SAA-reactive mouse monoclonal capture antibody Reu.86.5 (Hycult Biotechnology, Uden, The Netherlands). The plates are washed, followed by incubation of the samples. The plates are washed again, followed by incubation with the IgG fraction of the SAA1-reactive mouse monoclonal detection antibody Reu.86.1 (Hycult Biotechnology) coupled to horseradish peroxidase. After washing, the plates are incubated with the chromogen 3′3′5′5′tetramethylbenzidin (TMB, Carl Roth, Karlsruhe, Germany) dissolved in acetate buffer until the reaction is stopped by adding H2SO4. The absorption at 450–575 nm is read in a Versamax microplate reader and amyloid A protein concentrations are calculated by SOFTmax® PRO software (Molecular Devices, Sunnyvale, USA) according to a standard curve of purified SAA. The intra-assay and interassay coefficients of variation are both less than 10 % and the lower limit of detection of the amyloid A protein in fat extract is 1.6 ng/ml extraction fluid. Amyloid A protein concentration reference range of patients without AA amyloidosis is <11.6 ng/mg fat tissue [10, 61]. Recently Hycult has introduced a commercial SAA ELISA kit [108].

In a similar way, concentrations of other important amyloid proteins such as TTR and immunoglobulin light chains kappa and lambda can be measured using ELISA and nephelometry, respectively [64, 65]. Table 16.2 shows the cutoff values that were found in all four assays for the main amyloid types. However, after using the assays for a couple of years the new data have been analyzed to adapt the cutoff values for optimum prediction in daily practice (see Fig. 16.8). PPVs and NPVs have been based on 1886 routine fat tissue samples for AA, 742 samples for ATTR and 596 samples for AL-lambda and kappa immunochemical typing. Finally, 194 routine fat tissue samples have been used to test the assay. No amyloid was found in 34 samples and the remaining 160 amyloid-containing samples were analyzed for all four types. Typing was successful in 58 of 59 CR4+ samples (98 %), 39 of 45 CR3+ samples (87 %), 5 of 25 CR2+ samples (20 %) and 4 of 32 CR1+ samples (13 %). Figure 16.8 shows the decision tree currently used in Groningen for immunochemical typing of amyloid found in fat tissue.

Fig. 16.8
figure 8

Cutoff values of the concentration of AA, TTR, and kappa/lambda light chain ratios in fat tissue for optimum prediction of the type of amyloid as being used in our center in Groningen (GUARD) in daily practice. PPV is positive predictive value, NPV is negative predictive value, and CR is Congo red-stained severity grading 1+ to 4+

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Bijzet, J., van Gameren, I.I., Hazenberg, B.P.C. (2015). Fat Tissue Analysis in the Management of Patients with Systemic Amyloidosis. In: Picken, M., Herrera, G., Dogan, A. (eds) Amyloid and Related Disorders. Current Clinical Pathology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-19294-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-19294-9_16

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-19293-2

  • Online ISBN: 978-3-319-19294-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics